NCT07084168 Multimedia Aid for Genetic Testing in Gynecologic Oncology
| NCT ID | NCT07084168 |
| Status | Recruiting |
| Phase | — |
| Sponsor | UNC Lineberger Comprehensive Cancer Center |
| Condition | Ovary Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2024-10-10 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2024-10-10 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pilot study aims to estimate rates of genetic testing in patients with ovarian and endometrial cancer before and after the implementation of educational videos about genetic testing. Subjects will be asked to view one of three videos relevant to their cancer diagnosis and genetic testing, and have the option to complete a brief satisfaction survey. A chart review to evaluate rates of genetic testing ordered and referrals placed to Genetics before and after the implementation of the videos will be conducted. Up to 15-20% of ovarian cancer and 3-5% of endometrial cancer is due to inherited genetic mutation. Given this association, the National Comprehensive Cancer Network (NCCN) recommends genetic counseling and testing for all individuals with a diagnosis of ovarian cancer and endometrial cancer. Some challenges to obtaining genetic counseling and testing include missed identification and referral of eligible patients by providers, lack of provider knowledge, and busy clinic visits limiting time for informed consent and maintaining patient autonomy for genetic testing. Although heterogeneous, the literature supports multimedia use in cancer genetics. However, there is a paucity of data in the field of gynecologic oncology for the role of integrating a multimedia approach to genetic counseling.
Eligibility Criteria
Inclusion Criteria: In order to participate in this study, a subject must meet all of the eligibility criteria outlined below. * Reviewed informed consent to participate in the study. * Subject is willing and able to comply with study procedures based on the judgment of the investigator. * Age ≥ 18 years at the time of consent. * Diagnosis of ovarian cancer or endometrial cancer * Eligible for genetic testing * English or Spanish is the primary language Exclusion Criteria: * Previously completed genetic testing * Did not receive initial cancer-directed treatment at study site
Contact & Investigator
Katherine Tucker, MD
PRINCIPAL INVESTIGATOR
UNC Lineberger Comprehensive Cancer Center
Frequently Asked Questions
Who can join the NCT07084168 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Ovary Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07084168 currently recruiting?
Yes, NCT07084168 is actively recruiting participants. Contact the research team at luz_cuaboy@med.unc.edu for enrollment information.
Where is the NCT07084168 trial being conducted?
This trial is being conducted at Chapel Hill, United States.
Who is sponsoring the NCT07084168 clinical trial?
NCT07084168 is sponsored by UNC Lineberger Comprehensive Cancer Center. The principal investigator is Katherine Tucker, MD at UNC Lineberger Comprehensive Cancer Center. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.